These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 17550848)
1. Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Schaich M; Schlenk RF; Al-Ali HK; Döhner H; Ganser A; Heil G; Illmer T; Krahl R; Krauter J; Sauerland C; Büchner T; Ehninger G Haematologica; 2007 Jun; 92(6):763-70. PubMed ID: 17550848 [TBL] [Abstract][Full Text] [Related]
2. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. Schlenk RF; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G J Clin Oncol; 2004 Sep; 22(18):3741-50. PubMed ID: 15289486 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453 [TBL] [Abstract][Full Text] [Related]
4. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469 [TBL] [Abstract][Full Text] [Related]
5. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Grimwade D; Walker H; Oliver F; Wheatley K; Harrison C; Harrison G; Rees J; Hann I; Stevens R; Burnett A; Goldstone A Blood; 1998 Oct; 92(7):2322-33. PubMed ID: 9746770 [TBL] [Abstract][Full Text] [Related]
6. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22). Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Byrd JC; Mrózek K; Dodge RK; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Patil SR; Rao KW; Watson MS; Koduru PR; Moore JO; Stone RM; Mayer RJ; Feldman EJ; Davey FR; Schiffer CA; Larson RA; Bloomfield CD; Blood; 2002 Dec; 100(13):4325-36. PubMed ID: 12393746 [TBL] [Abstract][Full Text] [Related]
8. The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group. Schoch C; Haase D; Fonatsch C; Haferlach T; Löffler H; Schlegelberger B; Hossfeld DK; Becher R; Sauerland MC; Heinecke A; Wörmann B; Büchner T; Hiddemann W Br J Haematol; 1997 Dec; 99(3):605-11. PubMed ID: 9401073 [TBL] [Abstract][Full Text] [Related]
9. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group. Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W; Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of trisomy 8 in patients with acute myeloid leukemia. Elliott MA; Letendre L; Hanson CA; Tefferi A; Dewald GW Leuk Lymphoma; 2002 Mar; 43(3):583-6. PubMed ID: 12002762 [TBL] [Abstract][Full Text] [Related]
11. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression. Junghanss C; Waak M; Knopp A; Kleine HD; Kundt G; Leithäuser M; Hilgendorf I; Wolff D; Casper J; Freund M Neoplasma; 2005; 52(5):402-10. PubMed ID: 16151585 [TBL] [Abstract][Full Text] [Related]
12. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631 [TBL] [Abstract][Full Text] [Related]
13. Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial. Pfirrmann M; Ehninger G; Thiede C; Bornhäuser M; Kramer M; Röllig C; Hasford J; Schaich M; Lancet Oncol; 2012 Feb; 13(2):207-14. PubMed ID: 22197676 [TBL] [Abstract][Full Text] [Related]
14. Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461. Byrd JC; Lawrence D; Arthur DC; Pettenati MJ; Tantravahi R; Qumsiyeh M; Stamberg J; Davey FR; Schiffer CA; Bloomfield CD Clin Cancer Res; 1998 May; 4(5):1235-41. PubMed ID: 9607582 [TBL] [Abstract][Full Text] [Related]
15. Trisomy 8 as sole anomaly or with other clonal aberrations in acute myeloid leukemia: impact on clinical presentation and outcome. Jaff N; Chelghoum Y; Elhamri M; Tigaud I; Michallet M; Thomas X Leuk Res; 2007 Jan; 31(1):67-73. PubMed ID: 16814381 [TBL] [Abstract][Full Text] [Related]
16. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Farag SS; Archer KJ; Mrózek K; Vardiman JW; Carroll AJ; Pettenati MJ; Moore JO; Kolitz JE; Mayer RJ; Stone RM; Larson RA; Bloomfield CD Int J Oncol; 2002 Nov; 21(5):1041-51. PubMed ID: 12370753 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Dastugue N; Payen C; Lafage-Pochitaloff M; Bernard P; Leroux D; Huguet-Rigal F; Stoppa AM; Marit G; Molina L; Michallet M Leukemia; 1995 Sep; 9(9):1491-8. PubMed ID: 7658718 [TBL] [Abstract][Full Text] [Related]
18. Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial. Schlenk RF; Benner A; Hartmann F; del Valle F; Weber C; Pralle H; Fischer JT; Gunzer U; Pezzutto A; Weber W; Grimminger W; Preiss J; Hensel M; Fröhling S; Döhner K; Haas R; Döhner H; Leukemia; 2003 Aug; 17(8):1521-8. PubMed ID: 12886238 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630 [TBL] [Abstract][Full Text] [Related]